Long-term use of Viozan (sibenadet HCl) in patients with chronic obstructive pulmonary disease: results of a 1-year study. [electronic resource]
Producer: 20030418Description: S45-52 p. digitalISSN:- 0954-6111
- Administration, Inhalation
- Adrenergic beta-2 Receptor Agonists
- Adult
- Aged
- Aged, 80 and over
- Bronchodilator Agents -- administration & dosage
- Double-Blind Method
- Female
- Forced Expiratory Volume -- physiology
- Humans
- Long-Term Care
- Male
- Metered Dose Inhalers
- Middle Aged
- Pulmonary Disease, Chronic Obstructive -- drug therapy
- Quality of Life
- Receptors, Adrenergic, beta-2 -- administration & dosage
- Receptors, Dopamine D2 -- administration & dosage
- Smoking -- adverse effects
- Thiazoles -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.